Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.98USD
6:22pm BST
Change (% chg)

$0.48 (+7.38%)
Prev Close
$6.50
Open
$6.75
Day's High
$7.00
Day's Low
$6.57
Volume
35,702
Avg. Vol
52,646
52-wk High
$12.00
52-wk Low
$6.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.592
FY 2018 Dec '18 0.00 -0.621
Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 0.38 1.50 0.00 0.75
Quarter Ending Sep-19 4 0.40 1.60 0.00 0.80
Year Ending Dec-19 5 1.28 6.40 0.00 2.94
Year Ending Dec-20 5 15.92 79.60 0.00 11.72
Earnings (per share)
Quarter Ending Jun-19 5 -0.49 -0.40 -0.63 -0.64
Quarter Ending Sep-19 5 -0.49 -0.40 -0.66 -0.63
Year Ending Dec-19 5 -2.07 -1.81 -2.58 -2.40
Year Ending Dec-20 5 -1.86 -1.26 -2.24 -1.99
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.03 53.45
P/E High - Last 5 Yrs. -- 164.84 57.45
P/E Low - Last 5 Yrs. -- 52.13 28.04
Beta -- 1.19 0.94
Price to Sales (TTM) 78.85 40.94 9.15
Price to Book (MRQ) 1.61 11.82 4.14
Price to Tangible Book (MRQ) 1.61 17.11 4.94
Price to Cash Flow (TTM) -- 63.78 36.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.65
Dividend Yield - 5 Year Avg -- 0.05 0.72
Dividend 5 Year Growth Rate -- 0.93 3.10
Payout Ratio(TTM) -- 1.40 15.26

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 58.11 14.75
Sales (TTM) vs TTM 1 Yr. Ago -58.51 47.38 8.28
Sales - 5 Yr. Growth Rate -- 33.06 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago -21.51 -10.08 18.46
EPS (TTM) vs TTM 1 Yr. Ago -21.05 -- --
EPS - 5 Yr. Growth Rate -- 22.32 7.27
Capital Spending - 5 Yr. Growth Rate -- 25.14 8.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.42
Current Ratio (MRQ) 10.74 3.79 3.34
LT Debt to Equity (MRQ) 0.04 7.52 14.28
Total Debt to Equity (MRQ) 0.07 20.52 19.53
Interest Coverage (TTM) -- 35.45 14.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.42 50.24
Gross Margin - 5 Yr. Avg. -- 55.12 51.07
EBITD Margin (TTM) -2,294.03 -- --
EBITD - 5 Yr. Avg -578.02 -12.83 15.95
Operating Margin (TTM) -2,307.61 -115.80 -4.72
Operating Margin - 5 Yr. Avg. -581.97 -28.61 11.17
Pre-Tax Margin (TTM) -2,245.42 -116.03 -4.96
Pre-Tax Margin - 5 Yr. Avg. -580.25 -31.23 15.94
Net Profit Margin (TTM) -2,245.42 -121.64 -8.76
Net Profit Margin - 5 Yr. Avg. -580.25 -36.25 11.20
Effective Tax Rate (TTM) -- 17.19 20.61
Effective Tax Rate - 5 Yr. Avg. -- 19.00 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 38,984 8,975,967 740,344,753
Net Income/Employee (TTM) -875,344 1,596,651 86,451,148
Receivable Turnover (TTM) -- 11.29 5.63
Inventory Turnover (TTM) -- 2.42 3.63
Asset Turnover (TTM) 0.03 0.33 0.78

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -59.89 6.05 9.43
Return on Assets - 5 Yr. Avg. -55.82 6.23 10.42
Return on Investment (TTM) -66.44 7.44 11.71
Return on Investment - 5 Yr. Avg. -61.49 8.14 13.28
Return on Equity (TTM) -66.66 7.90 16.35
Return on Equity - 5 Yr. Avg. -102.18 9.25 14.84
  1 Year 3 Year 5 Year
Sales % -25.30 -13.87 --
EPS (TTM) % -18.30 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.08 -8.96 31 7
13 Week -22.16 -23.93 26 16
26 Week -17.62 -21.95 37 10
52 Week -38.51 -41.26 41 17
YTD -13.22 -23.40 28 10
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.44%
# of Holders: 107
Total Shares Held: 22,340,141
3 Mo. Net Change: 3,079,916
# New Positions: 18
# Closed Positions: 8
# Increased Positions: 57
# Reduced Positions: 26
# Net Buyers: 31
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.